Consulting
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | VENTURE MEDICAL |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$20,000 | — | |
| 2026 | VIALASE INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | — | |
| 2026 | OWLET |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — | |
| 2026 | ARDELYX |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$60,000 | — | |
| 2026 | ZIMMER BIOMET |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | — | |
| 2026 | ACESSO BIOLOGICS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$60,000 | — | |
| 2026 | BIOWOUND SOLUTIONS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | — | |
| 2026 | VIVEX BIOLOGICS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | — | |
| 2026 | WEX HEALTH |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | — | |
| 2026 | NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAF… |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$60,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| WEX HEALTH | 78 | $3,490,000 |
| AMERICAN OCCUPATIONAL THERAPY ASSOCIATION | 78 | $2,430,000 |
| AMGEN | 75 | $5,080,000 |
| GENENTECH | 75 | $3,650,000 |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | 74 | $2,110,000 |
| AMBULATORY SURGERY CENTER ASSOCIATION | 72 | $3,800,000 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 69 | $3,840,000 |
| LARGE UROLOGY GROUP PRACTICE ASSOCIATION | 65 | $5,110,000 |
| PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) | 57 | $2,350,000 |
| GILEAD SCIENCES, INC. | 54 | $3,080,000 |
| ALLERGAN INC | 53 | $3,070,000 |
| EMD SERONO, INC. | 53 | $2,400,000 |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. | 50 | $2,550,000 |
| ZIMMER BIOMET | 46 | $1,710,000 |
| ELI LILLY AND COMPANY | 44 | $2,260,000 |
| NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) | 42 | $2,140,000 |
| AMERICAN MEDICAL ASSOCIATION | 40 | $2,380,000 |
| DENDREON PHARMACEUTICALS LLC | 33 | $950,000 |
| ALNYLAM PHARMACEUTICALS | 30 | $1,490,000 |
| ANTIMICROBIAL INNOVATION ALLIANCE | 29 | $1,090,000 |
| Name | Disclosed Prior Position |
|---|---|
| LINDSAY BEALOR | |
| SHAWN BISHOP | |
| PAUL BRYAN CRONAN | |
| MARY GRACE DARCEY | |
| LAWREN D GEER | |
| CHRISTINA HOCHUL | |
| MICHAEL LEE | N/A |
| JOHN MCMANUS | Staff Director, Ways and Means Health Subcommittee |
| WILLIAM RHYNE | |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
| ABIGAIL SMITH | |
| ALANNA TEMME | LD; Rep. Jon Porter |
| CHASE M THOMAS | |
| BARRETT THORNHILL | LA, Sen. Crapo and Rep. Toomey. LA and Press Secretary, Rep. Norwood. |
| ALEX WHALEN |